The pharmacoepidemiology of COPD: recent advances and methodological discussion.
Burney
P
P
Dept of Public Health Services, London, UK. peter.burney@kcl.ac.uk
Suissa
S
S
Soriano
J B
JB
Vollmer
W M
WM
Viegi
G
G
Sullivan
S D
SD
Fabbri
L M
LM
Sin
D D
DD
Ernst
P
P
Coultas
D
D
Bourbeau
J
J
Mapel
D W
DW
Weiss
K
K
McLaughlin
T
T
Price
D
D
Sturkenboom
M C J M
MC
Taylor
R
R
Hagan
G W
GW
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D005060:Europe / Q000453:epidemiology; D005260:Female; D005544:Forecasting; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017891:Pharmacoepidemiology / Q000191:economics / Q000639:trends*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D011788:Quality of Life; D012129:Respiratory Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology